Search
for

    Sort by

    Research 61–90 of 1000+

    1. New Selenoderivatives as Antitumoral Agents InTech eBooks · 2011
    2. Louisiana Marinas and Boat Launches, LOSCO (2003) [marinas] Urologia Internationalis · 2003 · 1 citations
    3. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    4. Moving Chemoprevention Forward into the Most Promising Areas of Study Oncology Times · 2003
    5. The clinical applications of five-alpha reductase inhibitors. Canadian Journal of Urology · 2021 · 2 citations
    6. 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review BJUI · 2010 · 44 citations
    7. 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times? Cancer Epidemiology, Biomarkers & Prevention · 2022 · 1 citations
    8. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer 2008 · 108 citations
    9. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025
    10. Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential Translational Andrology and Urology · 2026
    11. Dutasteride: A Review of its Use in the Management of Prostate Disorders Clinical medicine insights · 2011 · 2 citations
    12. Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review) Oncology Reports · 2012 · 46 citations
    13. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations
    14. The Conception and Evaluation of Sexual Health Literature Sexual medicine reviews · 2016 · 3 citations
    15. Clinical application of 5α-reductase inhibitors Journal of endocrinological investigation · 2001 · 46 citations
    16. 5 Alpha-reductase inhibitors: whatʼs new? Current opinion in urology · 2003 · 47 citations
    17. Trailing the Path to Preventive Oncology Advances in cancer prevention · 2018 · 1 citations
    18. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    19. Prostate cancer update: 2007 Current Opinion in Internal Medicine · 2008
    20. Hair loss at 20 associated with prostate cancer risk later in life Cancer · 2011
    21. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    22. Male pattern baldness and the risk of prostate cancer Annals of Oncology · 2011 · 38 citations
    23. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    24. 5α- Reductase Inhibitors in Prostate Cancer: An Overview Austin Journal of Cancer and Clinical Research · 2017
    25. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    26. Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents. Revista chilena de nutrición · 2017 · 3 citations
    27. Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent HAMDAN MEDICAL JOURNAL · 2021
    28. Inhibition of 5α-reductase in the rat prostate by Cimicifuga racemosa Maturitas · 2006 · 7 citations
    29. Incidence of alopecia from endocrine therapies in cancer Journal of The American Academy of Dermatology · 2013
    30. Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition Endocrine Reviews · 2005 · 451 citations